A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

NCT03802617 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Uremic Pruritus

Interventions

DRUG: MR13A9
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.

Collaborators

[object Object]